FGFR4-IN-4
FGFR4-IN-4 (compound 693) is a FGFR4 inhibitor with anti-tumor activity, extracted from patent WO2018113584A1[1].
Product Specifications
CAS Number
2230973-67-6
UNSPSC
12352005
Target
FGFR
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/fgfr4-in-4.html
Solubility
10 mM in DMSO
Smiles
C=CC(N[C@H]1COC[C@H]1NC2=NC=C3C(C(N4CCC(OC)CC4)=NC(C5=C(Cl)C(OC)=CC(OC)=C5Cl)=C3)=N2)=O
Molecular Formula
C28H32Cl2N6O5
Molecular Weight
603.50
References & Citations
[1]YANG, Fei, et al. FGFR4 INHIBITOR, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF. WO2018113584A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
G3009-02-ML550 100 µL
Germinal Center Kinase (GC Kinase, GCK, B Lymphocyte Serine/threonine-protein Kinase, BL44, Mitogen-activated Protein Kinase Kinase Kinase Kinase 2, MAP4K2, MAPK/ERK Kinase Kinase Kinase 2, MEK Kinase Kinase 2, MEKKK 2, Rab8-interacting Protein, RAB8IP) (MaxLight 550) discontinued
Sign In for Pricing
View Details 
